Bioreactor development for stem cell expansion and controlled differentiation

James A. King*, William M Miller

*Corresponding author for this work

Research output: Contribution to journalReview article

156 Citations (Scopus)

Abstract

Widespread use of embryonic and adult stem cells for therapeutic applications will require reproducible production of large numbers of well-characterized cells under well-controlled conditions in bioreactors. During the past two years, substantial progress has been made towards this goal. Human mesenchymal stem cells expanded in perfused scaffolds retained multi-lineage potential. Mouse neural stem cells were expanded as aggregates in serum-free medium for 44 days in stirred bioreactors. Mouse embryonic stem cells expanded as aggregates and on microcarriers in stirred vessels retained expression of stem cell markers and could form embryoid bodies. Embryoid body formation from dissociated mouse embryonic stem cells, followed by embryoid body expansion and directed differentiation, was scaled up to gas-sparged, 2-l instrumented bioreactors with pH and oxygen control.

Original languageEnglish (US)
Pages (from-to)394-398
Number of pages5
JournalCurrent Opinion in Chemical Biology
Volume11
Issue number4
DOIs
StatePublished - Aug 1 2007

Fingerprint

Embryoid Bodies
Bioreactors
Stem cells
Stem Cells
Adult Stem Cells
Neural Stem Cells
Serum-Free Culture Media
Embryonic Stem Cells
Mesenchymal Stromal Cells
Gases
Oxygen
Scaffolds
Mouse Embryonic Stem Cells
Therapeutics

ASJC Scopus subject areas

  • Biochemistry

Cite this

@article{9860c418a0b1434e9770b0ffa241d6b8,
title = "Bioreactor development for stem cell expansion and controlled differentiation",
abstract = "Widespread use of embryonic and adult stem cells for therapeutic applications will require reproducible production of large numbers of well-characterized cells under well-controlled conditions in bioreactors. During the past two years, substantial progress has been made towards this goal. Human mesenchymal stem cells expanded in perfused scaffolds retained multi-lineage potential. Mouse neural stem cells were expanded as aggregates in serum-free medium for 44 days in stirred bioreactors. Mouse embryonic stem cells expanded as aggregates and on microcarriers in stirred vessels retained expression of stem cell markers and could form embryoid bodies. Embryoid body formation from dissociated mouse embryonic stem cells, followed by embryoid body expansion and directed differentiation, was scaled up to gas-sparged, 2-l instrumented bioreactors with pH and oxygen control.",
author = "King, {James A.} and Miller, {William M}",
year = "2007",
month = "8",
day = "1",
doi = "10.1016/j.cbpa.2007.05.034",
language = "English (US)",
volume = "11",
pages = "394--398",
journal = "Current Opinion in Chemical Biology",
issn = "1367-5931",
publisher = "Elsevier Limited",
number = "4",

}

Bioreactor development for stem cell expansion and controlled differentiation. / King, James A.; Miller, William M.

In: Current Opinion in Chemical Biology, Vol. 11, No. 4, 01.08.2007, p. 394-398.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Bioreactor development for stem cell expansion and controlled differentiation

AU - King, James A.

AU - Miller, William M

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Widespread use of embryonic and adult stem cells for therapeutic applications will require reproducible production of large numbers of well-characterized cells under well-controlled conditions in bioreactors. During the past two years, substantial progress has been made towards this goal. Human mesenchymal stem cells expanded in perfused scaffolds retained multi-lineage potential. Mouse neural stem cells were expanded as aggregates in serum-free medium for 44 days in stirred bioreactors. Mouse embryonic stem cells expanded as aggregates and on microcarriers in stirred vessels retained expression of stem cell markers and could form embryoid bodies. Embryoid body formation from dissociated mouse embryonic stem cells, followed by embryoid body expansion and directed differentiation, was scaled up to gas-sparged, 2-l instrumented bioreactors with pH and oxygen control.

AB - Widespread use of embryonic and adult stem cells for therapeutic applications will require reproducible production of large numbers of well-characterized cells under well-controlled conditions in bioreactors. During the past two years, substantial progress has been made towards this goal. Human mesenchymal stem cells expanded in perfused scaffolds retained multi-lineage potential. Mouse neural stem cells were expanded as aggregates in serum-free medium for 44 days in stirred bioreactors. Mouse embryonic stem cells expanded as aggregates and on microcarriers in stirred vessels retained expression of stem cell markers and could form embryoid bodies. Embryoid body formation from dissociated mouse embryonic stem cells, followed by embryoid body expansion and directed differentiation, was scaled up to gas-sparged, 2-l instrumented bioreactors with pH and oxygen control.

UR - http://www.scopus.com/inward/record.url?scp=34548134850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548134850&partnerID=8YFLogxK

U2 - 10.1016/j.cbpa.2007.05.034

DO - 10.1016/j.cbpa.2007.05.034

M3 - Review article

VL - 11

SP - 394

EP - 398

JO - Current Opinion in Chemical Biology

JF - Current Opinion in Chemical Biology

SN - 1367-5931

IS - 4

ER -